1,233
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Investigation into changes in inflammatory and immune cell markers in pre-diabetic patients from Durban, South Africa

, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2290282 | Received 09 Jun 2023, Accepted 28 Nov 2023, Published online: 15 Dec 2023

References

  • Ahmad R, Thomas R, Kochumon S, Sindhu S. 2017. Increased adipose tissue expression of IL‐18R and its ligand IL‐18 associates with inflammation and insulin resistance in obesity. Immun Inflamm Dis. 5(3):318–335. doi: 10.1002/iid3.170.
  • Anderson E, Gutierrez D, Hasty A. 2010. Adipose tissue recruitment of leukocytes. Curr Opin Lipidol. 21(3):172–177. doi: 10.1097/MOL.0b013e3283393867.
  • Arner P. 2002. Insulin resistance in Type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev. 18 Suppl 2(S2): s 5–S9. doi: 10.1002/dmrr.254.
  • American Diabetics Association (ADA). 2016. Classification and diagnosis of diabetes. Diabetes Care. 39: s 13–S22.
  • Baker R, Hayden M, Ghosh S. 2011. NF-κB, inflammation, and metabolic disease. Cell Metab. 13(1):11–22. doi: 10.1016/j.cmet.2010.12.008.
  • Bruce C, Hoy A, Turner N, Watt M, Allen T, Carpenter K, Cooney G, Febbraio M, Kraegen E. 2009. Over-expression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes. 58(3):550–558. doi: 10.2337/db08-1078.
  • Butcher M, Hallinger D, Garcia E, Machida Y, Chakrabarti S, Nadler J, Galkina E, Imai Y. 2014. Association of pro-inflammatory cytokines and islet resident leucocytes with islet dysfunction in Type 2 diabetes. Diabetologia. 57(3):491–501. doi: 10.1007/s00125-013-3116-5.
  • Chawla A, Nguyen K, Goh YS. 2011. Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol. 11(11):738–749. doi: 10.1038/nri3071.
  • Chomarat P, Banchereau J, Davoust J, Palucka AK. 2000. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol. 1(6):510–514. doi: 10.1038/82763.
  • Daryabor G, Atashzar M, Kabelitz D, Meri S, Kalantar K. 2020. The effects of Type 2 diabetes mellitus on organ metabolism and the immune system. Front Immunol. 11:1582. doi: 10.3389/fimmu.2020.01582.
  • Degirmenci I, Ozbayer C, Kebapci M, Kurt H, Colak E, Gunes H. 2019. Common variants of genes encoding TLR4 and TLR4 pathway members TIRAP and IRAK1 are effective on MCP1, IL-6, IL-1β, and TNFα levels in Type 2 diabetes and insulin resistance. Inflamm Res. 68(9):801–814. doi: 10.1007/s00011-019-01263-7.
  • Erridge C. 2010. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol. 87(6):989–999. doi: 10.1189/jlb.1209775.
  • Erridge C, Attina T, Spickett C, Webb D. 2007. A high-fat meal induces low-grade endotoxemia: evidence of novel mechanism of post-prandial inflammation. Am J Clin Nutr. 86(5):1286–1292. doi: 10.1093/ajcn/86.5.1286.
  • Evans J, Goldfine I, Maddux B, Grodsky G. 2002. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of Type 2 diabetes. Endocr Rev. 23(5):599–622. doi: 10.1210/er.2001-0039.
  • Fonseca V. 2007. Early identification and treatment of insulin resistance: impact on subsequent pre-diabetes and Type 2 diabetes. Clin Cornerstone. 8 Suppl 7:S7–S18. doi: 10.1016/s1098-3597(07)80017-2.
  • Gamede M, Mabuza L, Ngubane P, Khathi A. 2018. Effects of plant-derived oleanolic acid on selected parameters of glucose homeostasis in diet-induced pre-diabetic rat model. Molecules. 23(4):794. doi: 10.3390/molecules23040794.
  • Gamede M, Mabuza L, Ngubane P, Khathi A. 2019. Plant-derived oleanolic acid (OA) ameliorates risk factors of cardiovascular diseases in a diet-induced pre-diabetic rat model: effects on selected cardiovascular risk factors. Molecules. 24(2):340. doi: 10.3390/molecules24020340.
  • Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J. 2002. Serine phosphorylation of insulin substrate 1 by inhibitor κB kinase complex. J Biol Chem. 277(50):48115–48121. doi: 10.1074/jbc.M209459200.
  • Gaskins A, Wilchesky M, Mumford S, Whitcomb B, Browne R, Wactawski-Wende J, Perkins N, Schisterman E. 2012. Endogenous reproductive hormones and C-reactive protein across the menstrual cycle: the BioCycle study. Am J Epidemiol. 175(5):423–431. doi: 10.1093/aje/kwr343.
  • Govender L, Pillay K, Siwela M, Modi A, Mabhaudhi T. 2021. Assessment of nutritional status of four selected rural communities in KwaZulu-natal, South Africa. Nutrients. 13(9):2920. doi: 10.3390/nu13092920.
  • Graves D, Kayal R. 2008. Diabetic complications and dysregulated innate immunity. Front Biosci. 13(13):1227–1239. doi: 10.2741/2757.
  • Grundy S. 2012. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 59(7):635–643. doi: 10.1016/j.jacc.2011.08.080.
  • Hampton H, Chtanova T. 2019. Lymphatic migration of immune cells. Front Immunol. 10:1168. doi: 10.3389/fimmu.2019.01168.
  • Honda T, Uehara T, Matsumoto G, Arai S, Sugano M. 2016. Neutrophil left shift and white blood cell count as markers of bacterial infection. Clin Chim Acta. 457:46–53. doi: 10.1016/j.cca.2016.03.017.
  • International Diabetes Federation (IDF). 2019. IDF Diabetes Atlas, 9th Edition. Brussels. Belgium: International Diabetes Federation.
  • Jagannathan-Bogdan M, McDonnell M, Shin H, Rehman Q, Hasturk H, Apovian C, Nikolajczyk B. 2011. Elevated pro-inflammatory cytokine production by a skewed T-cell compartment requires monocytes and promotes inflammation in Type 2 diabetes. J Immunol. 186(2):1162–1172. doi: 10.4049/jimmunol.1002615.
  • Jornayvaz F, Shulman GI. 2012. Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. Cell Metab. 15(5):574–584. doi: 10.1016/j.cmet.2012.03.005.
  • Kolb H, Mandrup-Poulsen T. 2005. An immune origin of Type 2 diabetes? Diabetologia. 48(6):1038–1050. doi: 10.1007/s00125-005-1764-9.
  • Lee C, Adler A, Sandhu M, Sharp S, Forouhi N, Erqou S, Luben R, Bingham S, Khaw K, Wareham N. 2009. Association of C-reactive protein with Type 2 diabetes: prospective analysis and meta-analysis. Diabetologia. 52(6):1040–1047. doi: 10.1007/s00125-009-1338-3.
  • Luvuno M, Khathi A, Mabandla M. 2018. Voluntary ingestion of a high-fat high-carbohydrate diet: a model for pre-diabetes. Ponte. 74(5):5–11. doi: 10.21506/j.ponte.2018.5.11.
  • Luvuno M, Khathi A, Mabandla M. 2019. Diet-induced pre-diabetes: effects on oxidative stress and inflammatory biomarkers as agents for vascular complications in renal function. Ponte. 74:120–143. doi: 10.21506/j.ponte.2019.2.9.
  • Mabuza L, Gamede M, Maikoo S, Booysen I, Ngubane P, Khathi A. 2019. Cardioprotective effects of a ruthenium (II) Schiff base complex in diet-induced pre-diabetic rats. Diabetes Metab Syndr Obes. 12:217–223. doi: 10.2147/DMSO.S183811.
  • McLaughlin T, Liu L-F, Lamendola C, Shen L, Morton J, Rivas H, Winer D, Tolentino L, Choi O, Zhang H, et al. 2014. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol. 34(12):2637–2643. doi: 10.1161/ATVBAHA.114.304636.
  • Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol J, Colette C. 2006. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyper-glycemia in patients with Type 2 diabetes. JAMA. 295(14):1681–1687. doi: 10.1001/jama.295.14.1681.
  • Mustafa F. 2022. The cellular architecture of the primo vascular system. J Acupunct Meridian Stud. 15(1):4–11. doi: 10.51507/j.jams.2022.15.1.4.
  • Myles I. 2014. Fast food fever: reviewing the impacts of Western diet on immunity. Nutrition. 13:61.
  • Mzimela N, Ngubane P, Khathi A. 2019. The changes in immune cell concentration during the progression of pre-diabetes to Type 2 diabetes in a high-fat high-carbohydrate diet-induced pre-diabetic rat model. Autoimmunity. 52(1):27–36. doi: 10.1080/08916934.2019.1575820.
  • Ngcobo S, Nkambule B, Nyambuya T, Mokgalaboni K, Ntsethe A, Mxinwa V, Ziqubu K, Ntamo Y, Nyawo T, Dludla P. 2022. Activated monocytes as a therapeutic target to attenuate vascular inflammation and lower cardiovascular disease risk in patients with Type 2 diabetes: systematic review of preclinical and clinical studies. Biomed Pharmacother. 146:112579. doi: 10.1016/j.biopha.2021.112579.
  • Nikiforov N, Galstyan K, Nedosugova L, Elizova N, Kolmychkova K, Ivanova E. 2017. Pro-inflammatory monocyte polarization in Type 2 diabetes mellitus and coronary heart disease. VP. 1:192–195. doi: 10.20517/2574-1209.2017.21.
  • Nikolajczyk B, Jagannathan-Bogdan M, Shin H, Gyurko R. 2011. State of the union between metabolism and the immune system in Type 2 diabetes. Genes Immun. 12(4):239–250. doi: 10.1038/gene.2011.14.
  • Richard C, Wadowski M, Goruk S, Cameron L, Sharma A, Field C. 2017. Individuals with obesity and Type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Res Care. 5(1):e000379. doi: 10.1136/bmjdrc-2016-000379.
  • Robertson R, Harmon J, Tran P, Poitout V. 2004. β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in Type 2 diabetes. Diabetes. 53 Suppl 1(suppl_1):S119–S124. doi: 10.2337/diabetes.53.2007.s119.
  • Rydén L, Standl E, Bartnik M, Berghe G, Betteridge J, de Boer M, Cosentino F, Jönsson B, Laakso M, Malmberg K. 2007. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. Eur Heart J. 9(SC):C3–C74.
  • Schrauwen P. 2007. High-fat diet, muscular lipotoxicity and insulin resistance. Proc Nutr Soc. 66(1):33–41. doi: 10.1017/S0029665107005277.
  • Shi H, Kokoeva M, Inouye K, Tzameli I, Yin H, Flier J. 2006. TLR4 links innate immunity and fatty acid–induced insulin resistance. J Clin Invest. 116(11):3015–3025. doi: 10.1172/JCI28898.
  • Shrestha A, Marla V, Shrestha S, Neupane M. 2014. Giant cells and giant cell lesions of oral cavity-a review. Cumhuriyet Dent J. 17(2):192–204. doi: 10.7126/cdj.58140.1008002428.
  • Soehnlein O, Steffens S, Hidalgo A, Weber C. 2017. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 17(4):248–261. doi: 10.1038/nri.2017.10.
  • Sosibo A, Mzimela N, Ngubane P, Khathi A. 2022. Prevalence and correlates of pre-diabetes in adults of mixed ethnicities in the South African population: a systematic review and meta-analysis. PLOS One. 17(11):e0278347. doi: 10.1371/journal.pone.0278347.
  • Therrin A. 2018. Type 2 Diabetes Signs 'Detectable Years Before Diagnosis’ Health Report. London: Royal Charter.
  • Thompson A, Cooney G. 2000. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance. Diabetes. 49(11):1761–1765. doi: 10.2337/diabetes.49.11.1761.
  • Xia C, Rao X, Zhong J. 2017. Role of T-lymphocytes in Type 2 diabetes and diabetes-associated inflammation. J Diabetes Res. 2017:6494795–6494796. doi: 10.1155/2017/6494795.
  • Xu L, Kitade H, Ni Y, Ota T. 2015. Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease. Biomolecules. 5(3):1563–1579. doi: 10.3390/biom5031563.